We used antibody blocking to test the functional contribution of surface expression of these three prototypic NK cell inhibitory ligands—PD-L1, HLA-E, and MHC-I—on the killing of SK-N-SH tumor cells with PM21-NK cells. This evidence concerns the gene HLA-E and neoplasm.